Kairos Pharma, LTD. - KAPA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$602K
QoQ value delta ($000)
+$104K (+20.88%)
Implied price effect (QoQ)
-37.28%
Shares
Total shares
855,718
QoQ shares delta
+411,699 (+92.72%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (KAPA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 14 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 228 321,738 0.0%
VANGUARD GROUP INC 93 131,828 0.0%
TWO SIGMA INVESTMENTS, LP 66 94,008 0.0%
GEODE CAPITAL MANAGEMENT, LLC 51 72,833 0.0%
XTX Topco Ltd 34 48,494 0.0%
Aptus Capital Advisors, LLC 31 44,286 0.0%
SevenBridge Financial Group, LLC 31 44,286 0.0%
STATE STREET CORP 17 24,100 0.0%
HRT FINANCIAL LP 15 21,319 0.0%
Virtu Financial LLC 14 20,278 0.0%
TWO SIGMA ADVISERS, LP 10 15,142 0.0%
OSAIC HOLDINGS, INC. 9 13,045 0.0%
Tower Research Capital LLC (TRC) 3 4,227 0.0%
BANK OF AMERICA CORP /DE/ 0 134 0.0%